The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2019

Filed:

Dec. 27, 2013
Applicant:

Polyphor Ag, Allschwil, CH;

Inventors:

Frank Otto Gombert, Basel, CH;

Daniel Obrecht, Bättwil, CH;

Odile Sellier-Kessler, Baldersheim, FR;

Alexander Lederer, Basel, CH;

Christian Ludin, Oberwil, CH;

Manuella Schmitt-Billet, Hagental-le-Bas, FR;

Steffen Weinbrenner, Constance, DE;

Assignee:

POLYPHOR AG, Allschwil, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/64 (2006.01); C07K 14/81 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 7/64 (2013.01); C07K 14/811 (2013.01); A61K 38/00 (2013.01);
Abstract

β-Hairpin peptidomimetics of the general formula cyclo(-Xaa-Xaa-Thr-Xaa-Ser-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-) and pharmaceutically acceptable salts thereof, with Xaa, Xaa, Xaa, Xaa, Xaa, Xaa, Xaa, Xaa, Xaa, Xaaand Xaabeing amino acid residues of certain types which are defined in the description and the claims, have elastase inhibitory properties, especially against human neutrophil elastase, and can be used for preventing infections or diseases related to such infections in healthy individuals or for slowing infections in infected patients. The compounds of the invention can further be used where cancer, or immunological diseases, or pulmonary diseases, or cardiovascular diseases, or neurodegenerative diseases, or inflammation, or diseases related to inflammation, are mediated or resulting from elastase activity. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.


Find Patent Forward Citations

Loading…